Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocell...
Prof Richard Finn - Geffen School of Medicine at UCLA, Los Angeles, USA
Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma ( Prof Richard Finn - Geffen School of Medicine at UCLA, Los Angeles, USA )
13 Apr 2021
Cemiplimab plus ipilimumab for advanced NSCLC
Prof Byoung Yong Shim - The Catholic University of Korea, Suwon, South Korea
Cemiplimab plus ipilimumab for advanced NSCLC ( Prof Byoung Yong Shim - The Catholic University of Korea, Suwon, South Korea )
7 Apr 2021
IMpower133: Exploratory analysis of maintenance therapy in patients with exten...
Prof Martin Reck and Dr Antonio Passaro
IMpower133: Exploratory analysis of  maintenance therapy in patients with  extensive-stage small-cell lung cancer ( Prof Martin Reck and Dr Antonio Passaro )
1 Apr 2021
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 inserti...
Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passa...
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )
29 Mar 2021
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Mar 2021
Promise of personalised medicine for patients with prostate cancer
Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt ...
Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )
26 Feb 2021
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell c...
Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, ...
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )
26 Feb 2021
Latest developments in the treatment of mRCC
Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald
Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )
24 Feb 2021
Latest in NSCLC from WCLC 2020
Prof Solange Peters, Dr Melissa Johnson, Prof Heather Wakelee and Dr Jay Lee
Latest in NSCLC from WCLC 2020 ( Prof Solange Peters, Dr Melissa Johnson, Prof Heather Wakelee and Dr Jay Lee )
24 Feb 2021
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early t...
Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt A...
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )
19 Feb 2021
Evolving medical treatment in advanced/recurrent endometrial cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021
Diagnosis, testing and biomarkers in the individualisation of patient care with ...
Prof Andrea Necchi and Prof Eva Compérat
Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bladder cancer ( Prof Andrea Necchi and Prof Eva Compérat )
18 Feb 2021